The Employees' State Insurance Corporation (ESIC) on May 27, 2026, issued amendment for change of Overseas Manufacturer Manufacturing Site of following three firms in respective Rate Contracts.
The amendment has been issued on the request of the respective firms. The drug(s) supplied by these firms from their New Manufacturing Site shall continue to adhere to composition, strength, standards and packing as approved under the respective DGESIC Rate Contract(s) & conform to the standards and specifications as per the Drug & Cosmetic Act and any amendments thereof.
Kindly find the amendment table attached to the document below.
[U-25/12/Amend/Site-Change/2026-MedV (e-1681820)/166]
